Active, not recruitingNCT06731179

A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay

Studying Lyme disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ViraxBio Labs
Enrollment
160 target
Eligibility
15 years · All sexes
Timeline
20242026

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06731179 on ClinicalTrials.gov

Other trials for Lyme disease

Additional recruiting or active studies for the same condition.

See all trials for Lyme disease

← Back to all trials